A comprehensive review of three decades of research using the K6/ODC transgenic mouse model demonstrates that elevated polyamine biosynthesis serves as an autonomous promoter of epithelial tumorigenesis while coordinating profound alterations across the dermal microenvironment. First generated thirty years ago to investigate the metabolic requirements of the classic two-stage skin carcinogenesis paradigm, the model targets the constitutive expression of ornithine decarboxylase to the outer root sheath cells of hair follicles adjacent to the bulge stem cell niche through the keratin 6 promoter. To replicate the persistent enzymatic induction observed in developing tumors, the transgene was engineered with a premature stop codon at position 427, truncating the carboxyl terminus of the protein and substantially extending its cellular half-life compared to the native enzyme.
The established chemical model of two-stage cutaneous carcinogenesis traditionally requires an initiating event followed by repetitive application of non-mutagenic tumor promoters to elicit neoplastic outgrowth. In wild-type mice, a subthreshold topical application of a carcinogen such as 7,12-dimethylbenz(a)anthracene induces activating mutations in the cellular H-ras gene but fails to produce tumors on its own unless followed by chronic exposure to agents such as 12-O-tetradecanoylphorbol-13-acetate or repeated mechanical wounding. These promoting stimuli generate extensive epidermal hyperplasia, tissue edema, and persistent localized inflammation that trigger clonal expansion of initiated cells. In sharp contrast, investigations with K6/ODC transgenic animals established that targeted enzymatic overexpression bypasses the requirement for exogenous chemical promoters entirely. When newborn or adult K6/ODC mice received only a single topical exposure to 7,12-dimethylbenz(a)anthracene, epidermal papillomas arose within six to eight weeks. This heightened susceptibility persisted even when the transgene was maintained on the C57BL/6 background, a murine strain otherwise noted for strong inherent resistance to skin tumor promotion. Comparable tumor development occurred following solitary exposures to distinct classes of chemical carcinogens or acute doses of ultraviolet B irradiation, confirming that persistent polyamine synthesis provides sufficient promotional drive.
Cooperative signaling between heightened polyamine accumulation and defined oncogenic driver pathways proved essential for advancing benign lesions toward invasive malignant carcinomas. Cross-breeding K6/ODC mice with TG.AC mice carrying an activated v-Ha-ras transgene produced double-transgenic offspring that spontaneously formed cutaneous keratoacanthomas between five and eight weeks of age without requiring chemical initiation or environmental promotion. Parallel in vivo tracheal xenotransplantation assays utilizing primary keratinocytes isolated from newborn K6/ODC skin demonstrated that elevated ornithine decarboxylase activity alone, or isolated activation of downstream Ras effectors including the Raf-MEK-ERK cascade or phosphatidylinositol 3-kinase, could not convert normal epithelial cells into an invasive phenotype. Instead, malignant conversion required the concurrent activation of the Raf-MEK-ERK pathway alongside a defined threshold of elevated enzymatic activity. Furthermore, basal cell carcinomas arose when follicular ornithine decarboxylase overexpression was combined with heterozygous loss of the patched tumor suppressor gene, whereas mice with Odc haploinsufficiency exhibited marked resistance to two-stage carcinogenesis.
Lineage tracing in inducible transgenic reporter strains subsequently resolved the cellular origins of polyamine-promoted skin lesions by demonstrating the direct recruitment of quiescent follicular stem cells. In normal quiescent epidermis, stem cells positive for alpha-6 integrin and CD34 remain dormant within the follicle bulge region during physiological tissue maintenance, mobilizing only under the stress of mechanical injury or powerful exogenous promoting agents. To track this population without the secondary tissue distortion seen in constitutive K6/ODC animals, researchers paired an inducible ODC-ER transgene with K15CrePR1;R26R reporter mice, which activate beta-galactosidase expression permanently in keratin 15-positive bulge stem cells upon administration of RU486. Following topical application of 4-hydroxytamoxifen to induce cutaneous enzymatic activity de novo, marked progeny departed the dormant bulge niche and migrated continuously into both the upper follicular infundibulum and the interfollicular epidermis. This experiment established that elevated epithelial polyamine concentrations act as an intrinsic stimulus capable of mobilizing long-lived bulge stem cells. Because initiated stem cells harboring latent carcinogen-induced genetic alterations can persist indefinitely without expanding, polyamine-induced recruitment provides the crucial trigger necessary to drive these damaged progenitors into active transit-amplifying clonal expansions.
Mechanical abrasion studies further demonstrated that polyamine accumulation exacerbates wound-associated tissue dynamics to sustain tumor growth in the absence of exogenous mutagens. Cutaneous wounding functions as an endogenous promoting stimulus, and chronic non-healing wounds represent a recognized clinical risk factor for the emergence of nonmelanoma skin malignancies. When skin from K6/ODC or tamoxifen-induced ODC-ER mice was experimentally abraded, the tissue exhibited exaggerated epidermal hyperproliferation accompanied by severe, unresolved inflammation that culminated in the formation of benign papillomatous growths directly within the wound bed. While wild-type littermates resolved epidermal hyperplasia and normalized their proliferative index within two weeks post-injury, transgenic skin maintained a persistently elevated proliferative index and progressive tissue thickening. Administration of the synthetic anti-inflammatory glucocorticoid dexamethasone completely prevented these wound-induced papillomas, demonstrating that polyamines exacerbate underlying inflammatory cascades and mobilize stem cell reserves to maintain hyperplasia. Even in the absence of prior chemical initiation, sustained metabolic activity produces a microenvironment wherein physical trauma is sufficient to generate neoplastic tissue architecture.
Beyond stimulating intrinsic proliferation, elevated polyamines reprogram the surrounding dermal architecture by inducing neovascularization and modifying critical signal transduction cascades. Although proliferating cyst-lining epithelial cells in K6/ODC skin displayed elevated baseline mitotic indices, tumors regressing under alpha-difluoromethylornithine therapy maintained their elevated proliferative markers while exhibiting a profound, early loss of microvascular density followed by widespread apoptotic cell death. In untreated transgenic skin, increased dermal vascularization coincided with a marked reduction in pigment epithelium-derived factor, an endogenous anti-angiogenic mediator. Concurrently, polyamines directly bound to the regulatory beta-subunit of protein kinase CK2, an enzyme whose elevated expression correlates with poor clinical outcomes and immunosuppressive tumor microenvironments across human cancers. This direct molecular interaction promoted the translocation of CK2 from the cytoplasm into the nucleus of overexpressing keratinocytes, resulting in increased phosphorylation of the nucleolar phosphoprotein B23 and other nuclear substrates involved in transcriptional control and cell cycle progression. The co-localization of ornithine decarboxylase and CK2 within follicular cyst epithelium highlights how metabolic excess feeds into aberrant kinase networks that sustain pre-malignant tissue survival.
Transgenic models also revealed that polyamine elevation alters chromatin architecture through direct and indirect modulation of histone-modifying enzymes. Dermal and epidermal tissues from K6/ODC and ODC-Ras mice exhibited significant increases in intrinsic histone acetyltransferase activity, displaying preferential acetylation of lysine-12 on the amino-terminal tail of histone H4. Specifically, both p300/CBP-associated acetyltransferase activity and the Tip60 acetyltransferase enzyme were elevated downstream of polyamine overproduction. While intrinsic histone deacetylase activity also increased in transgenic skin, bulk chromatin analyses demonstrated that global nucleosomal histone acetylation levels remained largely stable. This finding indicates that polyamines facilitate highly targeted, locus-specific remodeling of chromatin rather than indiscriminate global hyperacetylation. By altering local DNA conformations and dictating transcription factor recruitment at select gene promoters, polyamine-driven epigenetic shifts permit divergent transcriptional outcomes across specific gene subsets. Complementary studies demonstrated that altered polyamine availability also shifts histone methylation patterns, such that putrescine depletion in myeloid cells increases histone 3 lysine 4 mono-methylation and histone 3 lysine 9 acetylation while lowering repressive trimethylation marks, linking polyamine metabolism directly to transcriptional programming.
Elevated polyamine biosynthesis within the epidermal compartment simultaneously directs non-cell-autonomous activation of underlying dermal fibroblasts, driving profound stromal remodeling and metabolic stress. Fibroblasts situated in the transgenic dermis displayed heightened expression of classical activation markers, including fibroblast activation protein, alpha-smooth muscle actin, latent transforming growth factor beta binding protein-1, transforming growth factor beta, and fibroblast growth factor 10, alongside podoplanin and the chemokines interleukin-8, CXCL2, and CXCL5. Dermal extracellular matrix deposition of tenascin-C and collagen rose substantially, accompanied by a noticeable reduction of the subcutaneous adipose layer. Mechanistically, this extensive stromal remodeling is driven in part by the rapid depletion of the polyamine amino acid precursors arginine and methionine, which triggers activation of the nutrient-sensing kinase general control nonderepressible 2. When K6/ODC mice were bred onto a GCN2-deficient genetic background, chemical carcinogen-induced skin tumor formation was markedly diminished, confirming that metabolic stress signaling through GCN2 is an obligate mediator of polyamine-promoted tumorigenesis and fibroblast activation.
Immune evasion represents another vital facet of polyamine-driven tumor promotion, as elevated cutaneous ornithine decarboxylase activity systematically blunts both innate and adaptive anti-tumor immune responses. Transgenic K6/ODC mice exhibited significant impairment of contact hypersensitivity responses following hapten challenge, demonstrating suppression of classic adaptive T-cell-mediated cutaneous immunity. This suppression resulted from local cytokine alterations that inhibited the migration and antigen-presenting capacity of dermal dendritic cells, thereby curtailing the recruitment of effector leukocytes to the site of antigen application. Similarly, when challenged with syngeneic tumor cells expressing model antigens such as ovalbumin or beta-galactosidase peptides, both K6/ODC and ODC-ER mice showed defective expansion of antigen-specific interferon-gamma-producing splenocytes, resulting in accelerated neoplastic growth compared to wild-type controls. The activation of GCN2 downstream of polyamine synthesis further shifted the local myeloid landscape, expanding populations of immunosuppressive myeloid-derived suppressor cells and favoring the polarization of M2-like macrophages. These combined immunosuppressive mechanisms shield newly initiated epithelial cells from cytotoxic clearance, establishing an immunological niche that permits uninterrupted tumor expansion.
Paradoxically, chronic polyamine overproduction also engages classical cellular stress responses, inducing localized DNA damage and establishing a pro-tumorigenic senescence-associated secretory phenotype. Epidermal and dermal layers of transgenic mice displayed elevated levels of the tumor suppressors p53, p21Waf1, p27Kip1, and Bax despite their high proliferative state. This contradictory phenotype arises because elevated ornithine decarboxylase activity stimulates polyamine catabolic oxidases, producing reactive oxygen species that inflict sublethal DNA damage and trigger the canonical p53-ATM stress response pathway. While extensive genotoxic stress often drives apoptotic cell death, sustained polyamine exposure frequently induces dermal fibroblasts to enter a stable senescent state characterized by increased p16 expression and high-level secretion of matrix metalloproteinase-9, transforming growth factor beta, CXCL2, and CXCL5. Pharmacological elimination of p16-positive senescent cells via ganciclovir administration profoundly suppressed carcinogen-induced tumor outgrowth, demonstrating that the secretome of polyamine-induced senescent fibroblasts directly supports epithelial neoplastic progression.
Beyond resolving long-standing oncological mechanisms, the K6/ODC mouse unexpectedly served as an indispensable translational model for a severe human developmental condition designated Bachmann-Bupp syndrome. Identified in 2018, this rare autosomal dominant disorder arises from heterozygous de novo mutations that introduce a premature stop codon into the human ODC gene. This truncation removes the final fourteen amino acids of the carboxyl terminus, replicating the exact stabilizing molecular modification originally engineered into the K6/ODC mouse thirty years prior. Whereas the murine transgene was confined to outer root sheath keratinocytes, the human mutation occurs ubiquitously, causing generalized somatic overgrowth, macrocephaly, global neurodevelopmental delays, muscular hypotonia, and severe sensorineural hearing loss alongside cutaneous alopecia and dermal follicular cysts identical to the transgenic mouse phenotype. Treated children experienced prompt hair regrowth, resolution of recurrent follicular cysts, and documented improvements in neuromuscular tone and developmental metrics, establishing an enduring translational legacy for the transgenic system.
Subject of Research: Mechanisms of polyamine-promoted skin tumorigenesis and stromal remodeling demonstrated by the K6/ODC transgenic mouse model
Article Title: The remarkable legacy of the K6/ODC mouse: mechanisms of polyamine-promoted tumorigenesis revealed
Article References: Gilmour, S. K. (2026). The remarkable legacy of the K6/ODC mouse: mechanisms of polyamine-promoted tumorigenesis revealed. Amino Acids, 58(1), Article 27. https://doi.org/10.1007/s00726-026-03514-4
Image Credits: AI Generated
DOI: 10.1007/s00726-026-03514-4
Keywords: ornithine decarboxylase, polyamine biosynthesis, K6/ODC transgenic mouse, skin carcinogenesis, tumor promotion, difluoromethylornithine, bulge stem cells, dermal fibroblasts, GCN2 kinase, chromatin remodeling, senescence-associated secretory phenotype, Bachmann-Bupp syndrome, myeloid-derived suppressor cells, tenascin-C, protein kinase CK2, histone acetylation, contact hypersensitivity
News Source: Drew Townsend. (November 12, 2026). Transgenic Mouse Model Reveals How Elevated Polyamines Drive Epithelial Skin Tumorigenesis. Scienmag.



